PREVALENCE AND CLINICAL PROFILE OF THYROID DISORDERS BY AGE AND GENDER IN A PAKISTANI POPULATION: A RETROSPECTIVE STUDY
Main Article Content
Keywords
Thyroid disorders, Prevalence, Age and gender, Pakistani population, Retrospective study
Abstract
Background: The thyroid gland produces hormones vital for metabolic rate, growth, and development, influencing functions such as digestion, cardiovascular health, and brain development. Thyroid disorders, including autoimmune conditions like primary hypothyroidism and Graves' disease, pose significant public health challenges globally, with prevalence rates of 5% to 10%. In Pakistan, hypothyroidism and hyperthyroidism rates are reported at 4.1% and 5.1%, respectively.
Objectives: This study aimed to examine the clinical profile of thyroid dysfunction concerning age and gender.
Methodology: A retrospective analysis was conducted from April to December 2020 at Jinnah Postgraduate Medical Centre in Karachi, Pakistan. Patient records of thyroid profiles (TSH, T3, and T4) were analyzed according to American Thyroid Association guidelines, utilizing R Studio (2024.04.0).
Results: The sample included 290 males and 1,050 females, with mean ages of 38.84 ± 16.02 years for males and 37.30 ± 12.65 years for females. Euthyroidism was the most prevalent condition (54%), more common in males (57%) than females (53%). Hyperthyroidism was more prevalent in females (22% vs. 14% in males), while overt hypothyroidism was higher in males (3.4% vs. 1.3% in females). Significant differences in thyroid disorder prevalence by gender and age were noted (p < 0.001).
Conclusion: The findings underscore the need for targeted screening and tailored treatment strategies, particularly for older males at heightened risk for severe thyroid conditions.
References
2. Shah, N., Ursani, T. J., Shah, N. A., & Raza, H. M. (2021). Prevalence and manifestations of hypothyroidism among the population of Hyderabad, Sindh, Pakistan. Pure and Applied Biology, 10(3), 668-675. https://doi.org/10.19045/bspab.2021.100069.
3. Silva, J. F., Ocarino, N. M., & Serakides, R. (2018). Thyroid hormones and female reproduction. Biology of Reproduction, 99(5), 907-921. https://doi.org/10.1093/biolre/ioy123
4. Wejaphikul, K., Groeneweg, S., Hilhorst-Hofstee, Y., Chatterjee, V. K., Peeters, R. P., & Meima, M. E., et al. (2019). Insight into molecular determinants of T3 vs T4 recognition from mutations in thyroid hormone receptor alpha and beta. The Journal of Clinical Endocrinology and Metabolism, 104(8), 3491-3500. https://doi.org/10.1210/jc.2018-02583
5. Ettleson, M. D., & Bianco, A. C. (2020). Individualized therapy for hypothyroidism: Is T4 enough for everyone? The Journal of Clinical Endocrinology and Metabolism, 105(9), 3090-3104. https://doi.org/10.1210/clinem/dgaa332.
6. Ahmed, R. G. (2018). Non-genomic actions of thyroid hormones during development. Applied Clinical Pharmacology and Toxicology, 10-18.
7. Soundarrajan, M., & Kopp, P. A. (2019). Thyroid hormone biosynthesis and physiology. Thyroid Disease Reproduction, 1-17.
8. Nillni, E. A. (2010). Regulation of the hypothalamic thyrotropin-releasing hormone (TRH) neuron by neuronal and peripheral inputs. Frontiers in Neuroendocrinology, 31(2), 134-156. https://doi.org/10.1016/j.yfrne.2009.10.004
9. Soldin, O. P., Chung, S. H., & Colie, C. (2013). The use of TSH in determining thyroid disease: How does it impact the practice of medicine in pregnancy? Journal of Thyroid Research, 22-31. https://doi.org/10.1155/2013/148157
10. Stockigt, J. (2003). Assessment of thyroid function: Towards an integrated laboratory-clinical approach. The Clinical Biochemist Reviews, 24(4), 109.
11. Diab, N., Daya, N. R., Juraschek, S. P., Martin, S. S., McEvoy, J. W., & Schultheiss, U. T., et al. (2019). Prevalence and risk factors of thyroid dysfunction in older adults in the community. Scientific Reports, 9, 13156. https://doi.org/10.1038/s41598-019-49896-9.
12. Sharma, P., Magar, N. T., & Mahesh, B. K. (2021). Prevalence of thyroid disorder in residents of western region of Nepal. International Journal of Applied Sciences and Biotechnology, 9(3), 169-175. https://doi.org/10.3126/ijasbt.v9i3.38849.
13. Hasanato, R., Mirah, J. A., Al-Shahrani, N., Alfulayyih, N., Almutairi, A., & Ogailan, B., et al. (2017). Incidence of thyroid diseases in female Saudi adults visiting a tertiary care hospital in Riyadh. Epidemiology (Sunnyvale), 7(1), 1. https://doi.org/10.4172/2161-1165.1000327.
14. Alqahtani, S. A. M. (2021). Prevalence and characteristics of thyroid abnormalities and its association with anemia in ASIR Region of Saudi Arabia: A cross-sectional study. Clinical Practice, 11, 494504. https://doi.org/10.4081/cp.2021.494504.
15. Javed, R. (2021). Incidence of thyroid diseases in local population. Pakistan Journal of Medical & Health Sciences, 17(01), 17.
16. Zainoren, N., & Said, A. H. (2021). Subclinical hypothyroidism and placenta abruption: A dangerous relationship during pregnancy. Borneo Journal of Medical Sciences, 18(3), 207-212.
17. Suzuki, S., Nishio, S. I., Takeda, T., & Komatsu, M. (2012). Gender-specific regulation of response to thyroid hormone in aging. Thyroid Research, 5(1), 1-8. https://doi.org/10.1186/1756-6614-5-1.
18. Jacobson, M. H., Howards, P. P., Darrow, L. A., Meadows, J. W., Kesner, J. S., Spencer, J. B., Terrell, M. L., & Marcus, M. (2018). Thyroid hormones and menstrual cycle function in a longitudinal cohort of premenopausal women. Paediatric and Perinatal Epidemiology, 32(3), 225-234. https://doi.org/10.1111/ppe.12457.
19. Eckstein, A. K., Loesch, C., Glowacka, D., Schott, M., Mann, K., Esser, J., & Morgenthaler, N. G. (2009). Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. British Journal of Ophthalmology, 93(8), 1052-1056. https://doi.org/10.1136/bjo.2008.154443.
20. Abraham-Nordling, M., Byström, K., Törring, O., Lantz, M., Berg, G., Calissendorff, J., et al. (2011). Incidence of hyperthyroidism in Sweden. European Journal of Endocrinology, 165(6), 899-905. https://doi.org/10.1530/EJE-11-0518.
21. Elenkova, A., Atanasova, I., Kirilov, G., Natchev, E., Ivanova, R., Kovatcheva, R., Vandeva, S., & Tcharaktchiev, D. (2017). Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: Data from a cross-sectional case-control study. Endocrine, 57(3), 486-493. https://doi.org/10.1007/s12020-017-1325-3.
22. Hamasaeed, P. A., Hussain, S. K., & Ashraf, S. M. (2019). Evaluation of thyroid-stimulating hormone and thyroid hormone concentrations in females with hypothyroidism and hyperthyroidism. Rafidain Journal of Science, 28(4), 1-7.